August 27, 2020
JCR Pharmaceuticals will kickstart full-scale business operations in Brazil for its lysosomal storage disorder treatments, the company said on August 26. As part of such efforts, JCR is scheduled to file for regulatory approval of JR-141, a blood-brain barrier (BBB)-penetrating...read more